Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.2B | 5.1B | 6.0B | 6.7B |
| Cost of revenue | 3.8B | 3.8B | 4.3B | 4.8B |
| Gross profit | 1.4B | 1.3B | 1.7B | 1.9B |
| Operating expense | ||||
| Research & development | 153M | 162M | 172M | 187M |
| Selling general and admin | 729M | 803M | 799M | 975M |
| Other operating expenses | — | — | — | — |
| Operating income | 563M | 379M | 706M | 716M |
| Non operating interest income | ||||
| Income | 30M | 37M | 139M | 19M |
| Expense | 112M | 118M | 131M | 185M |
| Other income expense | 67M | 395M | 56M | 3.0B |
| Pretax income | 548M | 693M | 770M | 3.5B |
| Tax provision | 111M | 723M | 172M | 1.2B |
| Net income | 437M | 2.6B | 481M | 2.4B |
| Basic EPS | 0.5 | 2.9 | 0.5 | 2.6 |
| Diluted EPS | 0.5 | 2.8 | 0.5 | 2.6 |
| Basic average shares | 866.9M | 890.1M | 901.2M | 902.4M |
| Diluted average shares | 878.3M | 903.4M | 915M | 915.3M |
| EBITDA | 963M | 1.1B | 1.2B | 4.0B |
| Net income from continuing op. | 437M | -30M | -1.4B | 2.5B |
| Minority interests | -25M | -18M | -34M | -32M |
| Preferred stock dividends | — | — | — | — |